After Hours Summary: GMCR +16.4%, CTRP +16.2%, CRM +5.4%, WB +4.8%, SINA +2.3%, SMTC -8.5% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings: GMCR +16.4%, CTRP +16.2%, CRM +5.4%, WB +4.8%, SINA +2.3%, NTAP +0.7%, CVO +0.6%, LB +0.6%, HI +0.2%
Companies trading higher in after hours in reaction to news: KBIO +687.4 (Former Retrophin CEO and current Turing Pharma CEO Martin Shkreli discloses ownership of ~1.625 mln shares; ~1.2 mln shares purchased from 11/16 to 11/17 at prices ranging from $0.30-2.45 per share), STEM +51.7% (reported six-month interim results for the first cohort in its ongoing Phase II Pathway Study in cervical spinal cord injury; data showed motor improvements in both strength and function), VTAE +23.3% (announced positive top-line results from a Phase 1 multiple ascending dose trial of VTP-43742; shown to be safe and generally well tolerated in healthy human volunteers), PLPM +6.4% (signed multi-currency processing agreement with BBVA Bancomer and launches its integrated payments hospitality solution for BBVA Bancomer merchants), TUMI +6.4% (to replace IPCM in the S&P SmallCap 600), CETV +1.9% (TCS Capital Management discloses 10.9% active stake in 13D filing; TCS sends letter to Board urging pursuit of strategic alternatives), RTN +1.5% (affirmed $0.67/share quarterly dividend; added $2 bln to repurchase program)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: SMTC -8.5%
Companies trading lower in after hours in reaction to news: SUNE -9.5% (Reuters reporting that Blackstone (BX) is rejecting rumors it was considering an investment in SUNE), AMAG -8.8% (received Complete Response Letter from the FDA for Makena (hydroxyprogesterone caproate injection) for the reduction of the risk of preterm birth), VLP -7.6% (announced an underwritten public offering of 4.25 mln units), AGN -3.2% (lower following WSJ report that the Treasury Department may issue anti inversion tax rules), DVA -1.7% (co's subsidiary received Civil Investigative Demand from the U.S. Department of Justice),